The role of substance P in stress and anxiety responses

K Ebner, N Singewald - Amino acids, 2006 - Springer
Substance P (SP) is one of the most abundant peptides in the central nervous system and
has been implicated in a variety of physiological and pathophysiological processes …

Behavioral effects of neuropeptides in rodent models of depression and anxiety

S Rotzinger, DA Lovejoy, LA Tan - Peptides, 2010 - Elsevier
In recent years, studies have advocated neuropeptide systems as modulators for the
behavioral states found in mood disorders such as depression and anxiety disorders …

Chronic ethanol and withdrawal differentially modulate pre-and postsynaptic function at glutamatergic synapses in rat basolateral amygdala

AK Lack, MR Diaz, A Chappell… - Journal of …, 2007 - journals.physiology.org
Withdrawal anxiety is a significant factor contributing to continued alcohol abuse in
alcoholics. This anxiety is long-lasting, can manifest well after the overt physical symptoms …

Anxiety-like behavior is modulated by a discrete subpopulation of interneurons in the basolateral amygdala

WA Truitt, PL Johnson, AD Dietrich, SD Fitz, A Shekhar - Neuroscience, 2009 - Elsevier
The basolateral amygdala (BL) is a putative site for regulating anxiety, where inhibition and
excitation respectively lead to decreases and increases in anxiety-like behaviors. The BL …

Substance P and the neurokinin-1 receptor: the new CRF

JR Schank, M Heilig - International review of neurobiology, 2017 - Elsevier
Substance P (SP) is an 11-amino acid neuropeptide of the tachykinin family that
preferentially activates the neurokinin-1 receptor (NK1R). First isolated 85 years ago and …

Substance P receptor antagonists in psychiatry: rationale for development and therapeutic potential

I Herpfer, K Lieb - CNS drugs, 2005 - Springer
Increasing evidence suggests that substance P (SP) and its receptor (neurokinin [NK]-1
receptor [NK1R]) might play an important role in the modulation of stress-related, affective …

Substance P at the nexus of mind and body in chronic inflammation and affective disorders.

MA Rosenkranz - Psychological bulletin, 2007 - psycnet.apa.org
For decades, research has demonstrated that chronic diseases characterized by
dysregulation of inflammation are particularly susceptible to exacerbation by stress and …

Species differences in tachykinin receptor distribution: Further evidence that the substance P (NK1) receptor predominates in human brain

M Rigby, R O'Donnell… - Journal of Comparative …, 2005 - Wiley Online Library
Marked species differences in the distribution of central tachykinin receptors are reported but
uncertainty remains about the ability of available ligands to detect NK2 and NK3 receptors in …

Do substance P and the NK1 receptor have a role in depression and anxiety?

S McLean - Current pharmaceutical design, 2005 - ingentaconnect.com
Research on Substance P (SP) has, until recently, focused on its role in pain and
inflammation. However, a report that NK1 receptor antagonists have utility in the treatment of …

Potential therapeutic targets for neurokinin-1 receptor antagonists

RA Duffy - Expert opinion on emerging drugs, 2004 - Taylor & Francis
The peptide substance P and its tachykinin receptor, neurokinin-1 (NK1), have been the
focus of considerable research for their role in a variety of both central and peripheral …